Bell HL, Blair HJ, Jepson Gosling SJ, Galler M, et al. Combination p53 activation and BCL-x(L)/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia. Leukemia 2024 Apr 10. doi: 10.1038/s41375-024-02241.
PMID: 38600316